Cargando…

Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars

Detalles Bibliográficos
Autores principales:	Olsen, Anja Weinreich, Rosenkrands, Ida, Holland, Martin J., Andersen, Peter, Follmann, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427952/ https://www.ncbi.nlm.nih.gov/pubmed/36042252 http://dx.doi.org/10.1038/s41541-022-00521-w

Ejemplares similares

A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Olsen, Anja Weinreich, et al.
Publicado: (2021)

Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis
por: Olsen, Anja Weinreich, et al.
Publicado: (2017)

Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation
por: Østergaard, Ole, et al.
Publicado: (2016)

A flow cytometry‐based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis
por: Grasse, Marco, et al.
Publicado: (2018)

Generation of a novel affibody molecule targeting Chlamydia trachomatis MOMP
por: Li, Mingyang, et al.
Publicado: (2021)

Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D
por: Erneholm, Karin, et al.
Publicado: (2016)

A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2016)

Overexpression of the Bam Complex Improves the Production of Chlamydia trachomatis MOMP in the E. coli Outer Membrane
por: Huynh, Dung T., et al.
Publicado: (2022)

Publisher Correction: Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo
por: Gwyn, Sarah, et al.
Publicado: (2021)

Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles
por: Cambridge, Chino D, et al.
Publicado: (2013)

Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis
por: Lorenzen, Emma, et al.
Publicado: (2015)

Complete Genome Sequence of Chlamydia trachomatis Ocular Serovar C Strain TW-3
por: Borges, Vítor, et al.
Publicado: (2014)

Severe Proctitis Caused by Chlamydia trachomatis Serovars D
por: Fukushima, Kazuaki, et al.
Publicado: (2016)

Chlamydia trachomatis Serovar Distribution in Patients with Follicular Conjunctivitis in Iran
por: Abedifar, Zohreh, et al.
Publicado: (2023)

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract
por: Wern, Jeanette Erbo, et al.
Publicado: (2017)

Combining individual Chlamydia trachomatis IgG antibodies MOMP, TARP, CPAF, OMP2, and HSP60 for tubal factor infertility prediction
por: van Ess, Eleanne F., et al.
Publicado: (2019)

Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Chlamydia trachomatis
por: Nguyen, Nina Dieu Nhien Tran, et al.
Publicado: (2021)

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection
por: Jiang, Pengfei, et al.
Publicado: (2015)

Comparison of clinical performance of antigen based-enzyme immunoassay (EIA) and major outer membrane protein (MOMP)-PCR for detection of genital Chlamydia trachomatis infection
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2016)

Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development
por: Hall, Jennifer V., et al.
Publicado: (2014)

Chlamydia trachomatis Cross-Serovar Protection during Experimental Lung Reinfection in Mice
por: Lanfermann, Christian, et al.
Publicado: (2021)

Chlamydia trachomatis Serovars Drive Differential Production of Proinflammatory Cytokines and Chemokines Depending on the Type of Cell Infected
por: Faris, Robert, et al.
Publicado: (2019)

Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge
por: Nguyen, Nina Dieu Nhien Tran, et al.
Publicado: (2020)

Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
por: Fairley, Stacie J, et al.
Publicado: (2013)

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2015)

Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro
por: Leonard, Cory Ann, et al.
Publicado: (2015)

Transformation of Sexually Transmitted Infection-Causing Serovars of Chlamydia trachomatis Using Blasticidin for Selection
por: Ding, Honglei, et al.
Publicado: (2013)

Genome sequencing of Chlamydia trachomatis serovars E and F reveals substantial genetic variation
por: Eder, Thomas, et al.
Publicado: (2017)

Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model
por: Olsen, Anja Weinreich, et al.
Publicado: (2010)

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
por: Lorenzen, Emma, et al.
Publicado: (2022)

A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ(+) CMI responses protects against a genital infection in minipigs
por: Bøje, Sarah, et al.
Publicado: (2016)

Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients
por: Lesiak-Markowicz, Iwona, et al.
Publicado: (2019)

Chlamydia Trachomatis Tonsillopharyngitis
por: Öztürk, Özmen, et al.
Publicado: (2012)

Genital Infiltrations of CD4(+) and CD8(+) T Lymphocytes, IgA(+) and IgG(+) Plasma Cells and Intra-Mucosal Lymphoid Follicles Associate With Protection Against Genital Chlamydia trachomatis Infection in Minipigs Intramuscularly Immunized With UV-Inactivated Bacteria Adjuvanted With CAF01
por: Erneholm, Karin, et al.
Publicado: (2019)

Rapid Detection of Chlamydia trachomatis and Typing of the Lymphogranuloma venereum associated L-Serovars by TaqMan PCR
por: Schaeffer, Anke, et al.
Publicado: (2008)

The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D infection in a murine model.
por: Lyons, Joseph M, et al.
Publicado: (2005)

Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections
por: Verweij, Stephan P, et al.
Publicado: (2014)

Molecular Characterization of the ClpC AAA+ ATPase in the Biology of Chlamydia trachomatis
por: Pan, Stefan, et al.
Publicado: (2023)

Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection
por: Qi, Man-Li, et al.
Publicado: (2017)

Publisher Correction: Dietary thiols accelerate aging of C. elegans
por: Gusarov, Ivan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn2elnm8roi263nsrt7b68io8l